Research shows IL-22 promotes chronic gammaherpesvirus infection in naïve B cells, suggesting a vital role in immune response.
Description Gammaherpesviruses are ubiquitous pathogens associated with various cancers including B-cell lymphomas. Gammaherpesviruses primarily target naïve B cells and drive a robust polyclonal germinal center response to increase their latent reservoir by manipulating B-cell differentiation to establish lifelong infection in memory B cells. The host factors exploited by gammaherpesviruses to establish chronic (latent) infection are largely unknown. IL-22, a member of the IL-10 family of cytokines, has a well-defined role in clearing bacterial and fungal infections. However, in viral infections, the role of IL-22 is unclear. Notably, there is no study that uncovers the role of IL-22 in gammaherpesvirus infection. Host IL-17A signaling has been reported to play a proviral role in chronic gammaherpesvirus infection. Given that IL-17A and IL-22 exhibit functional similarities in part while modulating germinal center reactions, it is worth exploring if IL-22, like IL-17A, has a role to play in gammaherpesvirus infection. Using murine gammaherpesvirus 68 (MHV68) as a tractable model, we report IL-22 as a contributory factor that promotes the gammaherpesvirus-driven germinal center response required for establishing chronic infection. We show that loss of IL-22 suppresses the gammaherpesvirus-driven germinal center response, establishment of viral latency, and viral reactivation. To our knowledge, this study is the first to unveil a proviral role of IL-22 in gammaherpesvirus infection. Funding Sources The work was supported by WMU Homer Stryker MD School of Medicine Startup grant. Topic Categories Viral Immunology (VIR)
No takes yet. Share an insight, caveat, or question.
Majeed et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: